First infusions with Eteplirsen orphan medicine from Qazaqstan Khalqyna fund reimbursement for DMD patients in Kazakhstan.
Patient started therapy with Eteplirsen. All exonskipping therapies in world are available for our patients.
#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #CentralAsia #SareptaTherapeutics #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany